$JHX

Singh Jesse G sold $16.0M of JHX

Singh Jesse G sold 530,100 shares of James Hardie Industries plc (JHX) at an average of $30.21 ($30.19–$30.23, $16.01M total) across 2 trades over 2026-08-21 to 2026-08-24.

Original reporting
SEC EDGAR · Singh Jesse G
Published Aug 25, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

The disclosed insider sale provides fresh material for traders assessing short-term price pressure.

02

Market read

First-report insider sale of $16M by a director; may influence short-term trading sentiment.

03

What to watch

No public statement from the director; could be tax planning or portfolio rebalancing.

Relevance 7/10Novelty 8/10Timing: filed today

Background

James Hardie Industries plc (JHX) is a global building products company listed in the US as an ADR.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Director Jesse G. Singh sold 530,100 shares for $16.0M, reducing his stake to 117,028 shares.

Expected impact

Possible modest downside pressure in the near term.

Evidence & confidence

The sale size ($16M) is material for a director, but no accompanying statement explains motive.

Market effects

Minimal; insider sale does not affect the broader building materials sector.

Limited to investors tracking James Hardie.

Low

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook.

Key entities

  • James Hardie Industries plc

    Building products manufacturer, ticker JHX.

  • Singh Jesse G.

    Director of James Hardie Industries plc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JHXMed

James Hardie upgrades FY27 cash flow guidance but not earnings, shares dip 5%

James Hardie (JHX) raised its FY27 free cash flow guidance by 20% to ~US$600M, but shares fell 5% as sales and earnings guidance remained unchanged. The company expects to achieve US$125M in cost synergies a year ahead of schedule. Management stated the guidance does not assume a housing recovery. FY26 free cash flow was US$425M, after deal and integration costs of ~US$207M.

$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.